Jean‐Pierre Lamagnère

Impact of Addition of Maintenance Therapy to Intensive Induction and Consolidation Chemotherapy for Childhood Acute Myeloblastic Leukemia: Results of a Prospective Randomized Trial, LAME 89/91

Yves Pérel, Anne Auvrignon, Thierry Leblanc et al. · Journal of Clinical Oncology · 2002 · 91 citations

Medicine, Oncology, Pharmacology +17

Immunologic indices in myelodysplastic syndromes

Philippe Colombat, M Renoux, Jean‐Pierre Lamagnère et al. · Cancer · 1988 · 61 citations

Life Sciences, Hematology, Immunology +12

Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach

F. Odoul, Chantal Le Guellec, Jean‐Pierre Lamagnère et al. · Fundamental and Clinical Pharmacology · 1999 · 50 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

High-Dose Therapy and Autologous Bone Marrow Transplantation in First Complete or Partial Remission for Poor Prognosis Hodgkin's Disease

Joël Fleury, Michel Legros, Philippe Colombat et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1996 · 20 citations

Medicine, Hematology, Oncology +10

A Multicentric Randomised Study of Alpha 2b Interferon (IFN) and Hydroxyurea (HU) with or without Cytosine-Arabinoside (Ara-c) in Previously Untreated Patients with Ph+ Chronic Myelocytic Leukemia (CML): Preliminary Cytogenetic Results

François Guilhot, Jean‐François Abgrall, Jean‐Luc Harousseau et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1993 · 19 citations

Medicine, Hematology, Pharmacotherapy +17